ARCHIVES

ImClone: Waksals To Pay $5 Million To Settle With SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 04 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

In Brief: Harris says She Won’t Ease up On Califano’s Antismoking Campaign – It Cost Him His Job

July 27, 1979

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

July 11, 2008

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989